Correction options for lipoatrophy in HIV-infected patients

Area of Science:

• Medical Science
• Dermatology
• Virology

Background:

• Lipoatrophy (LA) is a condition characterized by fat loss, often affecting the face, limbs, and buttocks.
• Facial lipoatrophy is a significant concern for patients with Human Immunodeficiency Virus (HIV) using highly active antiretroviral therapy (HAART).
• The causes of LA are multifactorial, involving HIV itself, its treatment, duration and severity of infection, and patient age.

Purpose of the Study:

• To review treatment options for facial volume loss in patients with lipoatrophy.
• To discuss the benefits and limitations of various reconstructive methods for lipoatrophy.
• To highlight the psychological and lifestyle impacts of facial lipoatrophy on HIV patients.

Main Methods:

• Literature review of scientific articles and clinical studies.
• Analysis of treatment modalities for facial volume restoration.
• Evaluation of patient-reported outcomes and psychological effects.

Main Results:

• Facial volume loss significantly impacts the appearance and mental health of HIV patients.
• Several treatment options exist, including antiretroviral therapy modification, surgical implants, and injectable fillers.
• Improvements in facial morphology can reduce anxiety and enhance the quality of life for affected individuals.

Conclusions:

• Facial lipoatrophy is a common and distressing side effect of HIV/HAART.
• Effective management of facial volume loss is crucial for improving patient adherence and well-being.
• Further research into optimal and long-lasting treatments for lipoatrophy is warranted.